Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation

被引：0
|
作者：
Chen, Yuxi [1 ]
Hua, Chen [1 ]
Lin, Xiaoxi [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 13期
关键词：
D O I：
10.1056/NEJMc2410533
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1259 / 1260
页数：2
相关论文
共 50 条
  • [1] Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation
    Fraissenon, Antoine
    Bayard, Charles
    Morin, Gabriel
    Benichi, Sandro
    Hoguin, Clement
    Protic, Sanela
    Zerbib, Lola
    Ladraa, Sophia
    Firpion, Marina
    Blauwblomme, Thomas
    Naggara, Olivier
    Duruisseaux, Michael
    Delous, Marion
    Boitel, Clothilde
    Bringuier, Pierre-Paul
    Payen, Lea
    Legendre, Christophe
    Kaltenbach, Sophie
    Balducci, Estelle
    Villarese, Patrick
    Asnafi, Vahid
    Bisdorff, Annouk
    Guibaud, Laurent
    Canaud, Guillaume
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 334 - 342
  • [2] Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation Reply
    Fraissenon, Antoine
    Guibaud, Laurent
    Canaud, Guillaume
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (13): : 1260 - 1260
  • [3] A Case Series of Patients With Kras KRAS G12C Mutation Treated With Sotorasib - Croatian Experience
    Seiwerth, F.
    Bitar, L.
    Franolic, I. Lukic
    Sajnic, A.
    Jakopovic, M.
    Samarzija, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S426 - S426
  • [4] KRAS G12C inhibition with sotorasib in metastatic colorectal cancer
    Severi, Christophe
    Van Cutsem, Eric
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (08) : 2792 - 2795
  • [5] Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation
    Zheng, Xinting
    Luo, Jiamin
    Liu, Wei
    Ashby, Charles R., Jr.
    Chen, Zhe-Sheng
    Lin, Lizhu
    DRUGS OF TODAY, 2022, 58 (04) : 175 - 185
  • [6] KRAS G12C mutation is not undruggable anymore
    Rodrigues, Manuel
    BULLETIN DU CANCER, 2020, 107 (02) : 145 - 145
  • [7] KRAS G12C mutation in NSCLC in a small genetic center: insights into sotorasib therapy response potential
    Eser, Metin
    Hekimoglu, Gulam
    Yarar, Murat Hakki
    Canbek, Sezin
    Ozcelik, Melike
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
    Fakih, Marwan G.
    Salvatore, Lisa
    Esaki, Taito
    Modest, Dominik P.
    Lopez-Bravo, David P.
    Taieb, Julien
    Karamouzis, Michalis V.
    Ruiz-Garcia, Erika
    Kim, Tae-Won
    Kuboki, Yasutoshi
    Meriggi, Fausto
    Cunningham, David
    Yeh, Kun-Huei
    Chan, Emily
    Chao, Joseph
    Saportas, Yaneth
    Tran, Qui
    Cremolini, Chiara
    Pietrantonio, Filippo
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (23): : 2125 - 2139
  • [9] KRAS G12C mutant allele amplification drives resistance to sotorasib in vitro
    Mohn, Deanna
    Saiki, Anne Y.
    Achanta, Pragathi
    Stapper, Andres Plata
    Lipford, J. Russell
    Verma, Rati
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2022, 17 : 727 - 733
12345